280 related articles for article (PubMed ID: 24797827)
1. Amniotic fluid-derived mesenchymal stem cells prevent fibrosis and preserve renal function in a preclinical porcine model of kidney transplantation.
Baulier E; Favreau F; Le Corf A; Jayle C; Schneider F; Goujon JM; Feraud O; Bennaceur-Griscelli A; Hauet T; Turhan AG
Stem Cells Transl Med; 2014 Jul; 3(7):809-20. PubMed ID: 24797827
[TBL] [Abstract][Full Text] [Related]
2. Amniotic Fluid Derived Stem Cells with a Renal Progenitor Phenotype Inhibit Interstitial Fibrosis in Renal Ischemia and Reperfusion Injury in Rats.
Monteiro Carvalho Mori da Cunha MG; Zia S; Oliveira Arcolino F; Carlon MS; Beckmann DV; Pippi NL; Luhers Graça D; Levtchenko E; Deprest J; Toelen J
PLoS One; 2015; 10(8):e0136145. PubMed ID: 26295710
[TBL] [Abstract][Full Text] [Related]
3. Efficiency of endovenous versus arterial administration of mesenchymal stem cells for ischemia-reperfusion-induced renal dysfunction in rats.
Zhuo W; Liao L; Fu Y; Xu T; Wu W; Yang S; Tan J
Transplant Proc; 2013 Mar; 45(2):503-10. PubMed ID: 23498785
[TBL] [Abstract][Full Text] [Related]
4. Additive effect of bFGF and selenium on expansion and paracrine action of human amniotic fluid-derived mesenchymal stem cells.
Park J; Lee JH; Yoon BS; Jun EK; Lee G; Kim IY; You S
Stem Cell Res Ther; 2018 Nov; 9(1):293. PubMed ID: 30409167
[TBL] [Abstract][Full Text] [Related]
5. Autologous bone marrow-derived mesenchymal stem cells for interstitial fibrosis and tubular atrophy: a pilot study.
Zhang L; Lai X; Guo Y; Ma J; Fang J; Li G; Xu L; Yin W; Chen Z
Ren Fail; 2021 Dec; 43(1):1266-1275. PubMed ID: 34493167
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cell therapy prevents interstitial fibrosis and tubular atrophy in a rat kidney allograft model.
Franquesa M; Herrero E; Torras J; Ripoll E; Flaquer M; Gomà M; Lloberas N; Anegon I; Cruzado JM; Grinyó JM; Herrero-Fresneda I
Stem Cells Dev; 2012 Nov; 21(17):3125-35. PubMed ID: 22494435
[TBL] [Abstract][Full Text] [Related]
7. The presence of human mesenchymal stem cells of renal origin in amniotic fluid increases with gestational time.
Rahman MS; Spitzhorn LS; Wruck W; Hagenbeck C; Balan P; Graffmann N; Bohndorf M; Ncube A; Guillot PV; Fehm T; Adjaye J
Stem Cell Res Ther; 2018 Apr; 9(1):113. PubMed ID: 29695308
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal Stromal Cells Are Retained in the Porcine Renal Cortex Independently of Their Metabolic State After Renal Intra-Arterial Infusion.
Sierra-Parraga JM; Munk A; Andersen C; Lohmann S; Moers C; Baan CC; Ploeg RJ; Pool M; Keller AK; Møller BK; Leuvenink H; Hoogduijn MJ; Jespersen B; Eijken M
Stem Cells Dev; 2019 Sep; 28(18):1224-1235. PubMed ID: 31280676
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Potential of Amniotic Fluid Derived Mesenchymal Stem Cells Based on their Differentiation Capacity and Immunomodulatory Properties.
Harrell CR; Gazdic M; Fellabaum C; Jovicic N; Djonov V; Arsenijevic N; Volarevic V
Curr Stem Cell Res Ther; 2019; 14(4):327-336. PubMed ID: 30806325
[TBL] [Abstract][Full Text] [Related]
10. Ex Vivo Administration of Mesenchymal Stromal Cells in Kidney Grafts Against Ischemia-reperfusion Injury-Effective Delivery Without Kidney Function Improvement Posttransplant.
Lohmann S; Eijken M; Møldrup U; Møller BK; Hunter J; Moers C; Leuvenink H; Ploeg RJ; Clahsen-van Groningen MC; Hoogduijn M; Baan CC; Keller AK; Jespersen B
Transplantation; 2021 Mar; 105(3):517-528. PubMed ID: 32956281
[TBL] [Abstract][Full Text] [Related]
11. The loss of renal dendritic cells and activation of host adaptive immunity are long-term effects of ischemia/reperfusion injury following syngeneic kidney transplantation.
Ozaki KS; Kimura S; Nalesnik MA; Sico RM; Zhang M; Ueki S; Ross MA; Stolz DB; Murase N
Kidney Int; 2012 May; 81(10):1015-1025. PubMed ID: 22278023
[TBL] [Abstract][Full Text] [Related]
12. The potential of mesenchymal stem cells derived from amniotic membrane and amniotic fluid for neuronal regenerative therapy.
Kim EY; Lee KB; Kim MK
BMB Rep; 2014 Mar; 47(3):135-40. PubMed ID: 24499672
[TBL] [Abstract][Full Text] [Related]
13. Autologous transplantation of amniotic fluid-derived mesenchymal stem cells into sheep fetuses.
Shaw SW; Bollini S; Nader KA; Gastaldello A; Mehta V; Filppi E; Cananzi M; Gaspar HB; Qasim W; De Coppi P; David AL
Cell Transplant; 2011; 20(7):1015-31. PubMed ID: 21092404
[TBL] [Abstract][Full Text] [Related]
14. Embryonic Stem Cell-Derived Mesenchymal Stem Cells (MSCs) Have a Superior Neuroprotective Capacity Over Fetal MSCs in the Hypoxic-Ischemic Mouse Brain.
Hawkins KE; Corcelli M; Dowding K; Ranzoni AM; Vlahova F; Hau KL; Hunjan A; Peebles D; Gressens P; Hagberg H; de Coppi P; Hristova M; Guillot PV
Stem Cells Transl Med; 2018 May; 7(5):439-449. PubMed ID: 29489062
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stromal cells from amniotic fluid are less prone to senescence compared to those obtained from bone marrow: An in vitro study.
Alessio N; Pipino C; Mandatori D; Di Tomo P; Ferone A; Marchiso M; Melone MAB; Peluso G; Pandolfi A; Galderisi U
J Cell Physiol; 2018 Nov; 233(11):8996-9006. PubMed ID: 29904927
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the neural differentiation potential of human mesenchymal stem cells from amniotic fluid and adult bone marrow.
Yan ZJ; Hu YQ; Zhang HT; Zhang P; Xiao ZY; Sun XL; Cai YQ; Hu CC; Xu RX
Cell Mol Neurobiol; 2013 May; 33(4):465-75. PubMed ID: 23478940
[TBL] [Abstract][Full Text] [Related]
17. Clinically Relevant Mesenchymal Stem/Stromal Cell Sheet Transplantation Method for Kidney Disease.
Oka M; Kameishi S; Cho YK; Song SU; Grainger DW; Okano T
Tissue Eng Part C Methods; 2023 Feb; 29(2):54-62. PubMed ID: 36719774
[TBL] [Abstract][Full Text] [Related]
18. IL-17A improves the efficacy of mesenchymal stem cells in ischemic-reperfusion renal injury by increasing Treg percentages by the COX-2/PGE2 pathway.
Bai M; Zhang L; Fu B; Bai J; Zhang Y; Cai G; Bai X; Feng Z; Sun S; Chen X
Kidney Int; 2018 Apr; 93(4):814-825. PubMed ID: 29132705
[TBL] [Abstract][Full Text] [Related]
19. Multipotent mesenchymal stromal cells from amniotic fluid: solid perspectives for clinical application.
Sessarego N; Parodi A; Podestà M; Benvenuto F; Mogni M; Raviolo V; Lituania M; Kunkl A; Ferlazzo G; Bricarelli FD; Uccelli A; Frassoni F
Haematologica; 2008 Mar; 93(3):339-46. PubMed ID: 18268281
[TBL] [Abstract][Full Text] [Related]
20. Human amniotic fluid-derived mesenchymal stem cells as therapeutic vehicles: a novel approach for the treatment of bladder cancer.
Bitsika V; Roubelakis MG; Zagoura D; Trohatou O; Makridakis M; Pappa KI; Marini FC; Vlahou A; Anagnou NP
Stem Cells Dev; 2012 May; 21(7):1097-111. PubMed ID: 21988169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
